Active (not recruiting) Phase 1 2025-522543-18-00

A Phase 1/1b First-in-Human Study of BMS-986506 in ccRCC

Phase 1 – testing safety in a small group of people

Conditions: Advanced Clear Cell Renal Cell Carcinoma

Sponsor: Bristol-Myers Squibb Services Unlimited Company

trial.available_in:

БГ

Overview

Trial status: Authorised

Who can participate

Age group: 18-64 years, 65+ years Gender: Female, Male Target enrollment: 48 participants

France (1)

Spain (1)

Status

Active (not recruiting)

Phase

Phase 1

Study type

INTERVENTIONAL

Sex

Male and female

Minimum age

18 Years

Healthy volunteers

Start date

09.02.2026

Registry ID

2025-522543-18-00

Source

euclinicaltrials.eu

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.